Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2019

May 29, 2019

30718_dirs_2019-05-29_fb155161-e6e0-4d36-8331-73604279aade.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-05-24

Reporting Person: Furlow Brenda S. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-24 Common Stock M 5400.00 $0.00 Acquired 7589.00 Direct
2019-05-24 Common Stock S 5400.00 $200.00 Disposed 2189.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-24 Stock Options (Right to buy) $94.35 M 5400.00 Acquired 2021-08-12 Common Stock (5400.00) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Common Stock (1759.00) 1759.00 Direct
Restricted Stock Units $ Common Stock (1724.00) 1724.00 Direct
Restricted Stock Units $ Common Stock (1374.00) 1374.00 Direct
Stock Option (Right to Buy) $108.49 2022-08-07 Common Stock (10000.00) 10000.00 Direct
Stock Options (Right to buy) $177.32 2025-08-08 Common Stock (9786.00) 9786.00 Direct
Stock Options (Right to buy) $177.32 2025-08-08 Common Stock (7339.00) 7339.00 Direct
Stock Options (Right to buy) $125.05 2024-08-09 Common Stock (9503.00) 9503.00 Direct
Stock Options (Right to buy) $125.05 2024-08-09 Common Stock (12760.00) 12760.00 Direct
Stock Options (Right to buy) $106.59 2023-08-18 Common Stock (14476.00) 14476.00 Direct
Stock Options (Right to buy) $106.59 2023-08-18 Common Stock (10857.00) 10857.00 Direct
Stock Options (Right to buy) $94.35 2021-08-12 Common Stock (9600.00) 9600.00 Direct

Footnotes

F1: Fully exercisable

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F3: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F4: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: 2,500 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.

F7: Vests 2,447 shares each on 8/9/2019, 8/9/2020 and 2,446 shares each on 8/9/2021, 8/9/2022.

F8: Vest 3,167 shares each on 8/9/2018, 8/9/2019 and 3,168 shares each on 8/9/2020, 8/9/2021.

F9: Vests 3,619 shares on each of 8/18/17, 8/18/18, 8/18/19 and 8/18/20.